Increasing intracellular bioavailable copper selectively targets prostate cancer cells.
Cater MA, Pearson HB, Wolyniec K, Klaver P, Bilandzic M, Paterson BM, Bush AI, Humbert PO, La Fontaine S, Donnelly PS, Haupt Y.
Cater MA, et al. Among authors: la fontaine s.
ACS Chem Biol. 2013 Jul 19;8(7):1621-31. doi: 10.1021/cb400198p. Epub 2013 May 24.
ACS Chem Biol. 2013.
PMID: 23656859